KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine Research (Coast), PO Box 230, 80108 Kilifi, Kenya.
J Antimicrob Chemother. 2011 Oct;66(10):2336-45. doi: 10.1093/jac/dkr314. Epub 2011 Aug 10.
Severe malnutrition is frequently complicated by sepsis, leading to high case fatality. Oral ciprofloxacin is a potential alternative to the standard parenteral ampicillin/gentamicin combination, but its pharmacokinetics in malnourished children is unknown.
Ciprofloxacin (10 mg/kg, 12 hourly) was administered either 2 h before or up to 2 h after feeds to Kenyan children hospitalized with severe malnutrition. Four plasma ciprofloxacin concentrations were measured over 24 h. Population analysis with NONMEM investigated factors affecting the oral clearance (CL) and the oral volume of distribution (V). Monte Carlo simulations investigated dosage regimens to achieve a target AUC(0-24)/MIC ratio of ≥125.
Data comprised 202 ciprofloxacin concentration measurements from 52 children aged 8-102 months. Absorption was generally rapid but variable; C(max) ranged from 0.6 to 4.5 mg/L. Data were fitted by a one-compartment model with first-order absorption and lag. The parameters were CL (L/h) = 42.7 (L/h/70 kg) × weight (kg)/70 × [1 + 0.0368 (Na(+) - 136)] × [1 - 0.283 (high risk)] and V (L) = 372 × (L/70 kg) × [1 + 0.0291 (Na(+) - 136)]. Estimates of AUC(0-24) ranged from 8 to 61 mg·h/L. The breakpoint for Gram-negative organisms was <0.06 mg/L with doses of 20 mg/kg/day and <0.125 mg/L with doses of 30 or 45 mg/kg/day. The cumulative fraction of response with 30 mg/kg/day was ≥80% for Escherichia coli, Klebsiella pneumoniae and Salmonella species, but <60% for Pseudomonas aeruginosa.
An oral ciprofloxacin dose of 10 mg/kg three times daily (30 mg/kg/day) may be a suitable alternative antibiotic for the management of sepsis in severely malnourished children. Absorption was unaffected by the simultaneous administration of feeds.
严重营养不良常并发败血症,导致病死率高。口服环丙沙星可能是替代标准的氨苄西林/庆大霉素联合用药的一种选择,但它在营养不良儿童中的药代动力学尚不清楚。
对肯尼亚因严重营养不良住院的儿童,在进食前 2 小时或进食后 2 小时内给予环丙沙星(10 mg/kg,12 小时 1 次)。在 24 小时内测量了 4 次环丙沙星的血浆浓度。采用 NONMEM 进行群体分析,以研究影响口服清除率(CL)和口服分布容积(V)的因素。通过蒙特卡罗模拟研究了达到 AUC(0-24)/MIC 比值≥125 的目标的剂量方案。
数据包括 52 名 8-102 月龄儿童的 202 次环丙沙星浓度测量值。吸收通常较快但具有变异性;Cmax 范围为 0.6-4.5 mg/L。数据通过一室模型拟合,具有一级吸收和滞后。参数为 CL(L/h)=42.7(L/h/70 kg)×[体重(kg)/70](0.75)×[1+0.0368(Na(+)-136)]×[1-0.283(高风险)]和 V(L)=372×(L/70 kg)×[1+0.0291(Na(+)-136)]。AUC(0-24)估计值范围为 8-61 mg·h/L。革兰氏阴性菌的折点为<0.06 mg/L,剂量为 20 mg/kg/天;<0.125 mg/L,剂量为 30 或 45 mg/kg/天。30 mg/kg/天的累积反应分数≥80%,适用于大肠杆菌、肺炎克雷伯菌和沙门氏菌,但<60%,适用于铜绿假单胞菌。
口服环丙沙星剂量为 10 mg/kg,每日 3 次(30 mg/kg/天)可能是治疗严重营养不良儿童败血症的一种合适的替代抗生素。同时给予食物不影响吸收。